price
CA
NASDAQ · CAI
Caris Life Sciences, Inc.
Healthcare · Biotechnology
$24.03
Down-$0.20 (-0.83%)
Updated Sep 10, 2026, 7:33 PM
SID Score
6.0/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 7.49B
- P/E ratio
- -34.61
- Dividend yield
- 0.00%
- 52-week range
- $14.19 – $29.32
- Volume
- 3.15M
- Avg. volume
- 1.42M
Price performance
CAI price history
1M range · 20 trading sessions · Daily adjusted prices
CAI closed at $24.03 after 20 trading sessions, up 7.95% for the selected period.
- Last close
- $24.03
- Period change
- +7.95%
- Period low
- $20.97
- Period high
- $28.01
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 9, 2026 | $24.00 | $24.96 | $23.95 | $24.03 | 3.15M |
| Sep 8, 2026 | $25.03 | $25.68 | $24.74 | $24.82 | 4.58M |
| Sep 4, 2026 | $24.88 | $25.14 | $24.4718 | $25.07 | 4.71M |
| Sep 3, 2026 | $24.94 | $25.34 | $23.62 | $25.32 | 6.43M |
| Sep 2, 2026 | $25.13 | $25.615 | $24.505 | $24.80 | 5.49M |
| Sep 1, 2026 | $25.60 | $25.62 | $24.55 | $24.78 | 4.03M |
| Aug 31, 2026 | $25.35 | $25.56 | $24.48 | $25.49 | 5.87M |
| Aug 28, 2026 | $26.15 | $26.75 | $25.47 | $25.63 | 3.84M |
| Aug 27, 2026 | $26.82 | $27.385 | $26.36 | $26.38 | 10.9M |
| Aug 26, 2026 | $27.70 | $28.0895 | $26.26 | $26.82 | 4.03M |
| Aug 25, 2026 | $26.19 | $28.32 | $25.77 | $28.01 | 6.82M |
| Aug 24, 2026 | $25.84 | $26.66 | $25.40 | $26.13 | 5.8M |
| Aug 21, 2026 | $24.73 | $26.60 | $24.32 | $26.27 | 6.39M |
| Aug 20, 2026 | $22.59 | $24.765 | $22.59 | $24.58 | 6.03M |
| Aug 19, 2026 | $21.92 | $22.94 | $21.92 | $22.76 | 6.56M |
| Aug 18, 2026 | $21.31 | $21.64 | $20.78 | $20.97 | 3.6M |
| Aug 17, 2026 | $22.00 | $22.19 | $21.52 | $21.63 | 2.77M |
| Aug 14, 2026 | $22.26 | $22.43 | $21.445 | $21.80 | 3.87M |
| Aug 13, 2026 | $22.84 | $23.12 | $22.14 | $22.18 | 2.97M |
| Aug 12, 2026 | $22.90 | $22.965 | $21.99 | $22.26 | 4.02M |
Latest CAI news
The latest Smart Investors Daily articles mentioning CAI.
Stock researchCompany · Dividend
Loading stock research…

